Breaking News Instant updates and real-time market news.

CLLS

Cellectis

$14.60

0.255 (1.78%)

14:47
12/03/19
12/03
14:47
12/03/19
14:47

Cellectis CEO calls notion company 'gave away' pipeline 'totally wrong'

Cellectis (CLLS) develops immunotherapies based on gene-edited CAR T-cells. In an exclusive interview with The Fly, the company's CEO Andre Choulika talked about the company's partnerships and pipeline. In a recent research note, a BTIG analyst claimed there is a perception among investors that Cellectis "gave away" its pipeline through partnerships and collaboration agreements. To say "we 'gave away our pipeline through our partnerships' is totally wrong," Choulika said. "We don't think we gave anything away. We just partnered our best products with I think, very good partners." The CEO said the company was looking to push those products further and added Cellectis has been getting great results for self-owned targets like T123, CS1 and C22. "For a small biotech company having three trials ongoing with three different products plus three partner products, I think it's exceptional on our side," he said. "I don't think we gave anything away. The company is becoming strong with our own pipeline of products but also if the partner products work it's a lot of income for the company. Don't forget that the company has $3.8B of potential milestones plus royalties on our partner product pipeline. It could be a lot of potential that could bring the company to a very interesting financial position at the end." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company.

  • 03

    Dec

  • 07

    Dec

CLLS Cellectis
$14.60

0.255 (1.78%)

03/14/19
WBLR
03/14/19
INITIATION
WBLR
Outperform
William Blair starts Cellectis with Outperform rating, $33 fair value estimate
William Blair analyst Raju Prasad last night initiated coverage of Cellectis with an Outperform rating and $33 fair value estimate. The company has seen a depressed valuation since the Allogene licensing deal, but the economics from the partnership and equity stake in Calyxt "set a valuation floor," Prasad tells investors in a research note. The analyst sees UCART123 being developed for acute myeloid leukemia and UCARTCS1 being developed for multiple myeloma as "riskier targets." However, he believes the CD22 target for acute lymphoblastic leukemia and non-Hodgkin lymphoma have been "de-risked from autologous therapies and could support upside."
05/24/19
SBSH
05/24/19
INITIATION
Target $22
SBSH
Neutral
Cellectis assumed with a Neutral at Citi
Citi analyst Yigal Nochomovitz assumed coverage of Cellectis with a Neutral rating and $22 price target. The analyst sees limited stock moving catalysts in the near-term, with UCART123 dose expansion data only in 2020.
08/09/19
BTIG
08/09/19
INITIATION
BTIG
Buy
Cellectis initiated with a Buy at BTIG
08/09/19
BTIG
08/09/19
INITIATION
Target $37
BTIG
Buy
Cellectis initiated with a Buy at BTIG
BTIG analyst Amanda Murphy initiated Cellectis with a Buy rating and a price target of $37 as part of her broader research note on CAR-T cell therapy names developing "off-the-shelf" engineered cell therapeutics for oncology. The analyst is positive on the company's partnership and collaboration agreements from its CAR-T pipeline deals with upcoming catalysts that include initial data from the ongoing Phase 1 study evaluating UCART123 for AML and the enrollment and dosing of the first patient in ' Phase 1 study evaluating UCART22 in AL expected this year.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$313.70

-0.17 (-0.05%)

, SPX

S&P 500

$0.00

(0.00%)

13:11
12/10/19
12/10
13:11
12/10/19
13:11
Periodicals
Pelosi says new USMCA deal improves on initial Trump version, Reuters says »

U.S. House Speaker Nancy…

SPY

SPDR S&P 500 ETF Trust

$313.70

-0.17 (-0.05%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:08
12/10/19
12/10
13:08
12/10/19
13:08
General news
10-Yr Note Auction Coupon Rate data reported »

10-Yr Note Auction Coupon…

13:08
12/10/19
12/10
13:08
12/10/19
13:08
General news
10-Yr Note Auction Total Amount data reported »

10-Yr Note Auction Total…

EVH

Evolent Health

$8.15

0.255 (3.23%)

13:05
12/10/19
12/10
13:05
12/10/19
13:05
Options
Evolent Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:04
12/10/19
12/10
13:04
12/10/19
13:04
Conference/Events
UBS services analysts to hold an analyst/industry conference call »

Services Analysts Geiger…

DBI

Designer Brands

$14.17

-2.84 (-16.70%)

12:57
12/10/19
12/10
12:57
12/10/19
12:57
Downgrade
Designer Brands rating change  »

Designer Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

12:55
12/10/19
12/10
12:55
12/10/19
12:55
Conference/Events
UBS retail analysts to hold an analyst/industry conference call »

Retail Analysts…

NTDOY

Nintendo

$0.00

(0.00%)

, TCEHY

Tencent

$0.00

(0.00%)

12:52
12/10/19
12/10
12:52
12/10/19
12:52
On The Fly
Game On: Nintendo Switch officially launches in China »

Welcome to "Game On," The…

NTDOY

Nintendo

$0.00

(0.00%)

TCEHY

Tencent

$0.00

(0.00%)

MSFT

Microsoft

$151.46

0.11 (0.07%)

EA

Electronic Arts

$102.03

-0.01 (-0.01%)

ATVI

Activision Blizzard

$55.35

0.97 (1.78%)

TTWO

Take-Two

$121.58

1.51 (1.26%)

SNE

Sony

$66.28

0.35 (0.53%)

CCOEY

Capcom

$0.00

(0.00%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 13

    Dec

  • 13

    Dec

MAT

Mattel

$11.99

-0.07 (-0.58%)

12:48
12/10/19
12/10
12:48
12/10/19
12:48
Conference/Events
Mattel participates in a conference call with UBS »

Gaming, Lodging &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

APO

Apollo Global

$44.16

0.365 (0.83%)

, TEN

Tenneco

$14.14

0.89 (6.72%)

12:47
12/10/19
12/10
12:47
12/10/19
12:47
Periodicals
Apollo Global bidding for Tenneco's powertrain unit, WSJ says »

Apollo Global (APO) has…

APO

Apollo Global

$44.16

0.365 (0.83%)

TEN

Tenneco

$14.14

0.89 (6.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GBT

Global Blood Therapeutics

$77.50

2.36 (3.14%)

12:45
12/10/19
12/10
12:45
12/10/19
12:45
Options
Global Blood Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ACAD

Acadia

$47.45

-0.5 (-1.04%)

, AXSM

Axsome Therapeutics

$48.94

3.785 (8.38%)

12:44
12/10/19
12/10
12:44
12/10/19
12:44
Conference/Events
Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call »

Biotech Analyst Duncan,…

ACAD

Acadia

$47.45

-0.5 (-1.04%)

AXSM

Axsome Therapeutics

$48.94

3.785 (8.38%)

BHVN

Biohaven Pharmaceutical

$54.49

1.52 (2.87%)

DNLI

Denali Therapeutics

$18.13

-0.16 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEO

American Eagle

$15.27

-0.075 (-0.49%)

, PLCE

Children's Place

$69.54

-0.45 (-0.64%)

12:44
12/10/19
12/10
12:44
12/10/19
12:44
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

AEO

American Eagle

$15.27

-0.075 (-0.49%)

PLCE

Children's Place

$69.54

-0.45 (-0.64%)

UNFI

United Natural Foods

$9.77

0.08 (0.83%)

VRA

Vera Bradley

$12.10

-0.04 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 18

    Dec

ASPU

Aspen Group

$6.96

-0.02 (-0.29%)

, PLAY

Dave & Buster's

$39.79

-0.48 (-1.19%)

12:44
12/10/19
12/10
12:44
12/10/19
12:44
Earnings
Notable companies reporting after market close »

Notable companies…

ASPU

Aspen Group

$6.96

-0.02 (-0.29%)

PLAY

Dave & Buster's

$39.79

-0.48 (-1.19%)

GME

GameStop

$6.28

-0.045 (-0.71%)

OLLI

Ollie's Bargain Outlet

$59.09

-1.19 (-1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 13

    Dec

  • 30

    Dec

PTON

Peloton

$32.48

-2.295 (-6.60%)

12:43
12/10/19
12/10
12:43
12/10/19
12:43
On The Fly
Peloton slumps as short-seller Citron weighs in, setting $5 price target »

Shares of Peloton (PTON)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCAR

Paccar

$80.95

-0.15 (-0.18%)

12:38
12/10/19
12/10
12:38
12/10/19
12:38
Hot Stocks
Paccar announces 32c regular dividend, $2.30 extra cash dividend »

Paccar's board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$134.17

-0.28 (-0.21%)

12:36
12/10/19
12/10
12:36
12/10/19
12:36
Earnings
JPMorgan sees Q4 trading revenue up 'meaningfully' year-over-year »

JPMorgan CFO Jennifer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

12:35
12/10/19
12/10
12:35
12/10/19
12:35
General news
Treasury Action: yields have continued to cheapen »

Treasury Action: yields…

WFC

Wells Fargo

$53.78

-0.13 (-0.24%)

12:29
12/10/19
12/10
12:29
12/10/19
12:29
Hot Stocks
Wells Fargo offers $0 trades for stocks and exchange traded funds »

Wells Fargo Advisors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 14

    Jan

LB

L Brands

$17.60

0.21 (1.21%)

12:25
12/10/19
12/10
12:25
12/10/19
12:25
Options
L Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

AZO

AutoZone

$1,249.46

78.16 (6.67%)

, AAP

Advance Auto Parts

$155.74

4.1 (2.70%)

12:22
12/10/19
12/10
12:22
12/10/19
12:22
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are searching for…

AZO

AutoZone

$1,249.46

78.16 (6.67%)

AAP

Advance Auto Parts

$155.74

4.1 (2.70%)

CHWY

Chewy

$24.92

0.75 (3.10%)

NLOK

NortonLifeLock

$26.25

0.82 (3.22%)

INTC

Intel

$56.64

0.12 (0.21%)

DERM

Dermira

$9.92

0.83 (9.13%)

CDMO

Avid Bioservices

$6.99

1.14 (19.49%)

SFIX

Stitch Fix

$26.93

1.76 (6.99%)

DBI

Designer Brands

$14.18

-2.83 (-16.64%)

CONN

Conn's

$14.29

-6.22 (-30.33%)

ROAD

Construction Partners

$16.60

-3.96 (-19.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 18

    Dec

  • 19

    Dec

  • 19

    Dec

  • 23

    Jan

GOOG

Alphabet

$1,344.39

0.47 (0.03%)

, GOOGL

Alphabet Class A

$1,342.51

0.26 (0.02%)

12:21
12/10/19
12/10
12:21
12/10/19
12:21
Periodicals
Google's proposed Fitbit deal faces DOJ scrutiny, NY Post reports »

Google's (GOOG)…

GOOG

Alphabet

$1,344.39

0.47 (0.03%)

GOOGL

Alphabet Class A

$1,342.51

0.26 (0.02%)

FIT

Fitbit

$6.81

0.105 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEN

Tenneco

$13.25

(0.00%)

, APO

Apollo Global

$44.22

0.425 (0.97%)

12:17
12/10/19
12/10
12:17
12/10/19
12:17
Periodicals
Breaking Periodicals news story on Tenneco, Apollo Global »

Apollo Global bidding for…

TEN

Tenneco

$13.25

(0.00%)

APO

Apollo Global

$44.22

0.425 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/10/19
12/10
12:17
12/10/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$68.97

-0.69 (-0.99%)

12:16
12/10/19
12/10
12:16
12/10/19
12:16
Periodicals
Exxon Mobil found not guilty of fraud in New York climate change case, WSJ says »

New York State Supreme…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.